Doxorubicin Hydrochloride Injectable, Liposomal
Product Images NDC 47335-049

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 47335-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl 20 mg Carton

Spl 20 mg Carton
This is a medication information sheet for Doxorubicin Hydrochloride Liposome Injection, a sterile cytotoxic agent that must be diluted prior to administration. The medication contains doxorubicin hydrochloride, USP 2mg that must be used in conjunction with 5% Dextrose Injection, USP. The medication is distributed by Sun Pharmaceutical Industries, Inc, and manufactured by Sun Pharmaceutical Industries Ltd. in India. The medication must be stored refrigerated between 2° C to 8° C and must be discarded if unused. The sheet also includes dosage and safety information.*
FDA Label Image

Spl 20 mg Vial

Spl 20 mg Vial
This text provides instructions for the use of Doxorubicin Hydrochloride liposome injection diluted with 5% Dextrose Injection, USP. It includes details of the dosage and storage instructions along with the cautionary note that the drug is a cytotoxic agent. The liposomal formulation must not be substituted and should only be administered after dilution. The drug must be kept refrigerated, and the vial should be retained in its carton until use. It also lists the manufacturer and distributor information along with the lot and expiration date.*
FDA Label Image

Spl 50 mg Carton

Spl 50 mg Carton
This is information about Doxorubicin Hydrochloride Liposome Injection, a cytotoxic agent used in intravenous infusion. It should be diluted before administration and it is a liposomal formulation. The usual dosage is not available, and it should be discarded if not used. The medication should be diluted with 5% Dextrose Injection, USP. It is distributed by Sun Pharmaceutical Industries Inc. from Cranbury, NJ, and manufactured by Sun Pharmaceutical Industries Limited from India. It is stored in a refrigerator between 2°C and 8°C and cannot be frozen. The rest of the text is unknown or illegible.*
FDA Label Image

Spl 50 mg Vial

Spl 50 mg Vial
This is a description of a medication called "DOXOrubicin Hydrochloride" which is administered through intravenous infusion only. The medication is sold in a 25 mL single-dose vial and distributed by Sun Pharmaceutical Industries. It is a cytotoxic agent that must be diluted before use. The dosage information can be found in the prescribing information. It is a liposomal formulation and should not be substituted. It must be stored in a refrigerator at a temperature of 2°C to 8°C (36°F to 46°F) and should not be frozen. The provided lot number is GUJDRUBS2839.*
FDA Label Image

Spl-doxorubicin-figure (Spl Doxorubicin Figure)

Spl-doxorubicin-figure (Spl Doxorubicin Figure)
This is a representation of a pegylated liposome, with MPEG-DSPE coating, an aqueous core entrapping doxorubicin HCI, and a liposomal bilayer.*
FDA Label Image

Spl-doxorubicin-figure1 (Spl Doxorubicin Figure1)

Spl-doxorubicin-figure1 (Spl Doxorubicin Figure1)
This text appears to provide results from a clinical trial comparing the use of Doxorubicin+Bortezomib with Bortezomib alone. The trial involved a total of 646 subjects, and found a statistically significant improvement in outcomes for the combination treatment, with an HR (hazard ratio) of 0.55 (95% CI 0.43, 0.71) and a p-value < 0.0001. The data is presented in a graph showing time (in months) and the number of subjects at risk for each treatment option.*
FDA Label Image

Spl-doxorubicin-structure (Spl Doxorubicin Structure)

FDA Label Image

Spl-doxorubicin-structure1 (Spl Doxorubicin Structure1)

FDA Label Image

Spl-doxorubicin-structure2 (Spl Doxorubicin Structure2)

Spl-doxorubicin-structure2 (Spl Doxorubicin Structure2)
The text describes the structural formula of HSPC which has a combination of nitrogen, oxygen, carbon, and hydrogen elements in it. The element's number range from 14 to 16.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.